116JPY
568.62 MJPY
20.13 BJPY
972.77 K
About SAPPORO CLINICAL LABORATORIES
Sector
Industry
Headquarters
Sapporo
Website
Employees (FY)
938
Founded
1965
ISIN
JP3321100004
FIGI
BBG000FHXZP4
Sapporo Clinical Laboratory Inc. engages in the business of clinical testing services for medical industries. It operates through the following segments: Clinical Testing, Dispensing Pharmacy, Medical Equipment Sales and Maintenance, and Others. The Clinical Testing segment provides contract laboratory tests for medical institutions. The Dispensing Pharmacy segment operates pharmacies that issue and dispense prescription medicines. The Medical Equipment Sales and Maintenance sells and maintains general and advanced medical and laboratory equipment. The Others segment develops, sells, and maintains clinical testing system software. The company was founded on September 22, 1965 and is headquartered in Sapporo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9776 is 1107 JPY — it has decreased by 0.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SAPPORO CLINICAL LABORATORIES stocks are traded under the ticker 9776.
SAPPORO CLINICAL LABORATORIES is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
9776 stock is 1.83% volatile and has beta coefficient of 0.21. Check out the list of the most volatile stocks — is SAPPORO CLINICAL LABORATORIES there?
Yes, you can track SAPPORO CLINICAL LABORATORIES financials in yearly and quarterly reports right on TradingView.
9776 stock has risen by 1.56% compared to the previous week, the month change is a 5.43% rise, over the last year SAPPORO CLINICAL LABORATORIES has showed a 16.07% decrease.
9776 net income for the last quarter is 85.68 M JPY, while the quarter before that showed 220.58 M JPY of net income which accounts for −61.16% change. Track more SAPPORO CLINICAL LABORATORIES financial stats to get the full picture.
Today SAPPORO CLINICAL LABORATORIES has the market capitalization of 3.70 B, it has decreased by 0.28% over the last week.
SAPPORO CLINICAL LABORATORIES dividend yield was 1.82% in 2022, and payout ratio reached 13.49%. The year before the numbers were 1.77% and 7.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 9776 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAPPORO CLINICAL LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 938.00 employees. See our rating of the largest employees — is SAPPORO CLINICAL LABORATORIES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAPPORO CLINICAL LABORATORIES technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAPPORO CLINICAL LABORATORIES stock shows the neutral signal. See more of SAPPORO CLINICAL LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAPPORO CLINICAL LABORATORIES EBITDA is 1.13 B JPY, and current EBITDA margin is 7.62%. See more stats in SAPPORO CLINICAL LABORATORIES financial statements.